Literature DB >> 17726191

The Avandia debate.

Zachary T Bloomgarden1.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17726191     DOI： 10.2337/dc07-zb09

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  4 in total

1.  Diabetes treatment and cardiovascular safety.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2011-04       Impact factor: 19.112

Review 2.  Diabetes Drugs and Cardiovascular Safety.

Authors:  Ji Cheol Bae
Journal:  Endocrinol Metab (Seoul)       Date:  2016-06-10

3.  Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses.

Authors:  Joshua D Wallach; Kun Wang; Audrey D Zhang; Deanna Cheng; Holly K Grossetta Nardini; Haiqun Lin; Michael B Bracken; Mayur Desai; Harlan M Krumholz; Joseph S Ross
Journal:  BMJ       Date:  2020-02-05

Review 4.  Redefining the role of thiazolidinediones in the management of type 2 diabetes.

Authors:  Anthony H Barnett
Journal:  Vasc Health Risk Manag       Date:  2009-04-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.